| Mr Bruce A Wallstedt, MD | |
|
6323 Canterbury Close, Brentwood, TN 37027-4870 | |
| (615) 504-9479 | |
| (615) 730-7334 |
| Full Name | Mr Bruce A Wallstedt |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 6323 Canterbury Close, Brentwood, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770578882 | NPI | - | NPPES |
| 3086317 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD25914 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Guardian Home Care Of Nashville, Llc | Franklin, TN | Home health agency |
| Adoration Home Health, Llc | Nashville, TN | Home health agency |
| Amedisys Home Health Care | Smyrna, TN | Home health agency |
| Amedisys Home Health | Murfreesboro, TN | Home health agency |
| Deaconess Homecare 1 | Mount juliet, TN | Home health agency |
| Guardian Hospice Of Nashville, Llc | Franklin, TN | Hospice |
| Encompass Hospice Of Tennessee | Nashville, TN | Hospice |
| Williamson Medical Center | Franklin, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bluesky Housecalls, Llc | 3476859257 | 5 |
News Archive
PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate RenalGuard® at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), May 25-28, 2010, in Paris, France. More than 11,000 clinicians and professionals are expected to attend this event.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to increasing competition from other biologic agents, Amgen/Pfizer/Takeda's Enbrel (etanercept)—the leading therapy in the psoriasis drug market in 2008—will account for less than one-fifth of sales in the overall market in 2018. In 2008, Enbrel garnered half of the psoriasis drug market share in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Melanoma is devastating on many fronts: rates are rising dramatically among young people, it is deadly if not caught early, and from a biological standpoint, the disease tends to adapt to even the most modern therapies, known as VEGF inhibitors.
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
› Verified 5 days ago
| Entity Name | Southeastern Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356379382 PECOS PAC ID: 2466364997 Enrollment ID: O20050125000997 |
News Archive
PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate RenalGuard® at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), May 25-28, 2010, in Paris, France. More than 11,000 clinicians and professionals are expected to attend this event.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to increasing competition from other biologic agents, Amgen/Pfizer/Takeda's Enbrel (etanercept)—the leading therapy in the psoriasis drug market in 2008—will account for less than one-fifth of sales in the overall market in 2018. In 2008, Enbrel garnered half of the psoriasis drug market share in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Melanoma is devastating on many fronts: rates are rising dramatically among young people, it is deadly if not caught early, and from a biological standpoint, the disease tends to adapt to even the most modern therapies, known as VEGF inhibitors.
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
› Verified 5 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20050207000666 |
News Archive
PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate RenalGuard® at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), May 25-28, 2010, in Paris, France. More than 11,000 clinicians and professionals are expected to attend this event.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to increasing competition from other biologic agents, Amgen/Pfizer/Takeda's Enbrel (etanercept)—the leading therapy in the psoriasis drug market in 2008—will account for less than one-fifth of sales in the overall market in 2018. In 2008, Enbrel garnered half of the psoriasis drug market share in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Melanoma is devastating on many fronts: rates are rising dramatically among young people, it is deadly if not caught early, and from a biological standpoint, the disease tends to adapt to even the most modern therapies, known as VEGF inhibitors.
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
› Verified 5 days ago
| Entity Name | Bluesky Housecalls, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073986410 PECOS PAC ID: 3476859257 Enrollment ID: O20160303001434 |
News Archive
PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate RenalGuard® at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), May 25-28, 2010, in Paris, France. More than 11,000 clinicians and professionals are expected to attend this event.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to increasing competition from other biologic agents, Amgen/Pfizer/Takeda's Enbrel (etanercept)—the leading therapy in the psoriasis drug market in 2008—will account for less than one-fifth of sales in the overall market in 2018. In 2008, Enbrel garnered half of the psoriasis drug market share in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Melanoma is devastating on many fronts: rates are rising dramatically among young people, it is deadly if not caught early, and from a biological standpoint, the disease tends to adapt to even the most modern therapies, known as VEGF inhibitors.
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Bruce A Wallstedt, MD 6323 Canterbury Close, Brentwood, TN 37027-4870 Ph: (615) 504-9479 | Mr Bruce A Wallstedt, MD 6323 Canterbury Close, Brentwood, TN 37027-4870 Ph: (615) 504-9479 |
News Archive
PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate RenalGuard® at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), May 25-28, 2010, in Paris, France. More than 11,000 clinicians and professionals are expected to attend this event.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to increasing competition from other biologic agents, Amgen/Pfizer/Takeda's Enbrel (etanercept)—the leading therapy in the psoriasis drug market in 2008—will account for less than one-fifth of sales in the overall market in 2018. In 2008, Enbrel garnered half of the psoriasis drug market share in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Melanoma is devastating on many fronts: rates are rising dramatically among young people, it is deadly if not caught early, and from a biological standpoint, the disease tends to adapt to even the most modern therapies, known as VEGF inhibitors.
GE Healthcare today announced FDA clearance of the CARESCAPE™ Monitor B650, a flexible patient monitoring solution that supports efficient clinical decision-making. The CARESCAPE Monitor B650 improves data integration and connectivity by directly linking to the GE Healthcare CARESCAPE portfolio of monitoring products-including the latest bedside, central station and transport monitors-as well as existing GE Healthcare monitors and peripheral third-party devices.
› Verified 5 days ago
Dr. Monica Leigh Davis, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1195 Old Hickory Blvd, Suite 103, Brentwood, TN 37027 Phone: 615-373-2000 Fax: 615-891-5021 | |
Dr. Nancy A Wolfe-sidberry, M.S., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5046 Thoroughbred Ln, Brentwood, TN 37027 Phone: 615-370-8080 Fax: 615-371-8906 | |
Dr. Sreedhar Samudrala, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1195 Old Hickory Blvd, Suite 103, Brentwood, TN 37027 Phone: 615-373-2000 Fax: 615-891-5001 | |
Helen K Chung-hussain, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 782 Old Hickory Blvd Ste 203, Brentwood, TN 37027 Phone: 615-371-1619 Fax: 615-371-8420 | |
Amy Louise Melvin, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1150 Cressy Ln, Brentwood, TN 37027 Phone: 615-473-3686 | |
Debra Kay Campbell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7110 Town Center Way Ste 4, Brentwood, TN 37027 Phone: 615-660-0000 Fax: 615-377-0000 | |
Gary Michael, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 Westwood Pl Ste 110, Brentwood, TN 37027 Phone: 615-206-2462 Fax: 833-983-2043 |